A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Clinical trial NCT00536770 · SUSPENDED

Trial details

NCT number: NCT00536770
Sponsor: Novacea
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2007-09-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.